Amifampridine
Top View
- FIRDAPSE Can Cause Seizures
- Preferred Drug List 4-Tier Small Group
- Medicaid List of Covered Drugs (Formulary)
- Emtree Terms Changed in September 2013
- Product Monograph Including Patient Medication Information
- 2020 Medicaid Preapproval Criteria
- FEP 5 Tier Rx Drug Formulary (607) Standard Option
- 3,4-Diaminopyridine Treatment for Lambert-Eaton Myasthenic Syndrome in Adults: a Meta-Analysis of Randomized Controlled Trials
- Atul Kamar Sood, Et Al. V. Catalyst Pharmaceutical Partners, Inc., Et Al
- State and Specialty Pharmacy Drug Reimbursement Rates
- Specialty Pipeline Monthly Update September 2018
- Medicare Model Guidelines Draft V8.0 1 of 97
- Advancing Health Through Innovation: New Drug Approvals 2019
- Amifampridine
- WHO Drug Information Vol. 20, No. 4, 2006
- Firdapse and Ruzurgi
- Pharmacy Medical Necessity Guidelines: Amifampridine (Firdapse®, Ruzurgi®) Effective: January 12, 2021
- Drugs for Rare Diseases: Evolving Trends in Regulatory and Health Technology Assessment Perspectives [Environmental Scan, Issue 42]